213 related articles for article (PubMed ID: 22565991)
1. Studies on coagulation incompatibilities for xenotransplantation.
Bulato C; Radu C; Simioni P
Methods Mol Biol; 2012; 885():71-89. PubMed ID: 22565991
[TBL] [Abstract][Full Text] [Related]
2. Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation.
Miwa Y; Yamamoto K; Onishi A; Iwamoto M; Yazaki S; Haneda M; Iwasaki K; Liu D; Ogawa H; Nagasaka T; Uchida K; Nakao A; Kadomatsu K; Kobayashi T
Xenotransplantation; 2010; 17(1):26-37. PubMed ID: 20149186
[TBL] [Abstract][Full Text] [Related]
3. Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro.
Lee KG; Lee H; Ha JM; Lee YK; Kang HJ; Park CG; Kim SJ
Xenotransplantation; 2012; 19(3):186-95. PubMed ID: 22702470
[TBL] [Abstract][Full Text] [Related]
4. Pig BMSCs Transfected with Human TFPI Combat Species Incompatibility and Regulate the Human TF Pathway in Vitro and in a Rodent Model.
Ji H; Li X; Yue S; Li J; Chen H; Zhang Z; Ma B; Wang J; Pu M; Zhou L; Feng C; Wang D; Duan J; Pan D; Tao K; Dou K
Cell Physiol Biochem; 2015; 36(1):233-49. PubMed ID: 25967963
[TBL] [Abstract][Full Text] [Related]
5. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.
Kopp CW; Siegel JB; Hancock WW; Anrather J; Winkler H; Geczy CL; Kaczmarek E; Bach FH; Robson SC
Transplantation; 1997 Mar; 63(5):749-58. PubMed ID: 9075849
[TBL] [Abstract][Full Text] [Related]
6. Xenotransplantation of solid organs in the pig-to-primate model.
Ekser B; Rigotti P; Gridelli B; Cooper DK
Transpl Immunol; 2009 Jun; 21(2):87-92. PubMed ID: 18955143
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
[TBL] [Abstract][Full Text] [Related]
8. Production of cloned pigs expressing human thrombomodulin in endothelial cells.
Yazaki S; Iwamoto M; Onishi A; Miwa Y; Hashimoto M; Oishi T; Suzuki S; Fuchimoto D; Sembon S; Furusawa T; Liu D; Nagasaka T; Kuzuya T; Ogawa H; Yamamoto K; Iwasaki K; Haneda M; Maruyama S; Kobayashi T
Xenotransplantation; 2012; 19(2):82-91. PubMed ID: 22497510
[TBL] [Abstract][Full Text] [Related]
9. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
[TBL] [Abstract][Full Text] [Related]
10. Coagulation and the xenograft endothelium.
Cowan PJ
Xenotransplantation; 2007 Jan; 14(1):7-12. PubMed ID: 17214700
[TBL] [Abstract][Full Text] [Related]
11. Functional difference between membrane-bound and soluble human thrombomodulin.
Miwa Y; Yazaki S; Iwamoto M; Suzuki S; Iwasaki K; Haneda M; Yamamoto K; Maruyama S; Onishi A; Kobayashi T
Transplantation; 2015 Apr; 99(4):702-9. PubMed ID: 25643141
[TBL] [Abstract][Full Text] [Related]
12. The coagulation barrier in xenotransplantation: incompatibilities and strategies to overcome them.
Cowan PJ; d'Apice AJ
Curr Opin Organ Transplant; 2008 Apr; 13(2):178-83. PubMed ID: 18685300
[TBL] [Abstract][Full Text] [Related]
13. Protein S is a cofactor for tissue factor pathway inhibitor.
Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
[TBL] [Abstract][Full Text] [Related]
14. TFPI-dependent activities of protein S.
Peraramelli S; Rosing J; Hackeng TM
Thromb Res; 2012 May; 129 Suppl 2():S23-6. PubMed ID: 22425215
[TBL] [Abstract][Full Text] [Related]
15. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
Hedner U; Erhardtsen E
Ann Med; 2000 Dec; 32 Suppl 1():68-72. PubMed ID: 11209985
[TBL] [Abstract][Full Text] [Related]
16. Coagulation dysregulation as a barrier to xenotransplantation in the primate.
Lin CC; Cooper DK; Dorling A
Transpl Immunol; 2009 Jun; 21(2):75-80. PubMed ID: 19000927
[TBL] [Abstract][Full Text] [Related]
17. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
[TBL] [Abstract][Full Text] [Related]
18. Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation.
Gollackner B; Mueller NJ; Houser S; Qawi I; Soizic D; Knosalla C; Buhler L; Dor FJ; Awwad M; Sachs DH; Cooper DK; Robson SC; Fishman JA
Transplantation; 2003 Jun; 75(11):1841-7. PubMed ID: 12811243
[TBL] [Abstract][Full Text] [Related]
19. Factors in xenograft rejection.
Robson SC; Schulte am Esch J; Bach FH
Ann N Y Acad Sci; 1999 Jun; 875():261-76. PubMed ID: 10415573
[TBL] [Abstract][Full Text] [Related]
20. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
Bajaj SP; Joist JH
Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
